Logo image of FRGE

FORGE GLOBAL HOLDINGS INC (FRGE) Stock Fundamental Analysis

NYSE:FRGE - New York Stock Exchange, Inc. - US34629L1035 - Common Stock - Currency: USD

0.65  -0.02 (-2.85%)

After market: 0.678 +0.03 (+4.31%)

Fundamental Rating

3

Overall FRGE gets a fundamental rating of 3 out of 10. We evaluated FRGE against 223 industry peers in the Capital Markets industry. FRGE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRGE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FRGE has reported negative net income.
In the past year FRGE has reported a negative cash flow from operations.
FRGE had negative earnings in each of the past 5 years.
FRGE had negative operating cash flow in 4 of the past 5 years.
FRGE Yearly Net Income VS EBIT VS OCF VS FCFFRGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -25.17%, FRGE is doing worse than 91.03% of the companies in the same industry.
FRGE has a worse Return On Equity (-29.67%) than 86.10% of its industry peers.
Industry RankSector Rank
ROA -25.17%
ROE -29.67%
ROIC N/A
ROA(3y)-28.68%
ROA(5y)-19.39%
ROE(3y)-33.39%
ROE(5y)-23.24%
ROIC(3y)N/A
ROIC(5y)N/A
FRGE Yearly ROA, ROE, ROICFRGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

FRGE's Gross Margin of 99.15% is amongst the best of the industry. FRGE outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of FRGE has remained more or less at the same level.
FRGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 99.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5YN/A
FRGE Yearly Profit, Operating, Gross MarginsFRGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for FRGE has been increased compared to 1 year ago.
FRGE has a worse debt/assets ratio than last year.
FRGE Yearly Shares OutstandingFRGE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
FRGE Yearly Total Debt VS Total AssetsFRGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

FRGE has an Altman-Z score of -0.31. This is a bad value and indicates that FRGE is not financially healthy and even has some risk of bankruptcy.
FRGE has a worse Altman-Z score (-0.31) than 80.72% of its industry peers.
FRGE has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of FRGE (0.03) is better than 83.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.31
ROIC/WACCN/A
WACCN/A
FRGE Yearly LT Debt VS Equity VS FCFFRGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

FRGE has a Current Ratio of 4.74. This indicates that FRGE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.74, FRGE belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
FRGE has a Quick Ratio of 4.74. This indicates that FRGE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FRGE (4.74) is better than 87.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.74
Quick Ratio 4.74
FRGE Yearly Current Assets VS Current LiabilitesFRGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.77% over the past year.
Looking at the last year, FRGE shows a quite strong growth in Revenue. The Revenue has grown by 13.62% in the last year.
The Revenue for FRGE have been decreasing by -14.76% on average. This is quite bad
EPS 1Y (TTM)30.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
Revenue 1Y (TTM)13.62%
Revenue growth 3Y-14.76%
Revenue growth 5YN/A
Sales Q2Q%-2.46%

3.2 Future

FRGE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.21% yearly.
FRGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.00% yearly.
EPS Next Y37.52%
EPS Next 2Y26.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year35.73%
Revenue Next 2Y30%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRGE Yearly Revenue VS EstimatesFRGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M
FRGE Yearly EPS VS EstimatesFRGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FRGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FRGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRGE Price Earnings VS Forward Price EarningsFRGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRGE Per share dataFRGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

FRGE's earnings are expected to grow with 26.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.21%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORGE GLOBAL HOLDINGS INC

NYSE:FRGE (3/7/2025, 8:04:01 PM)

After market: 0.678 +0.03 (+4.31%)

0.65

-0.02 (-2.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners38.36%
Inst Owner Change-1.83%
Ins Owners9.11%
Ins Owner Change-1.93%
Market Cap122.17M
Analysts76.67
Price Target3.75 (476.92%)
Short Float %1.97%
Short Ratio4.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.32%
Min EPS beat(2)-12.69%
Max EPS beat(2)12.04%
EPS beat(4)3
Avg EPS beat(4)11.37%
Min EPS beat(4)-12.69%
Max EPS beat(4)31%
EPS beat(8)4
Avg EPS beat(8)-0.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.8%
Min Revenue beat(2)-15.84%
Max Revenue beat(2)-11.75%
Revenue beat(4)1
Avg Revenue beat(4)-5.54%
Min Revenue beat(4)-15.84%
Max Revenue beat(4)7.08%
Revenue beat(8)2
Avg Revenue beat(8)-4.99%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.42
BVpS1.19
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.17%
ROE -29.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 99.15%
FCFM N/A
ROA(3y)-28.68%
ROA(5y)-19.39%
ROE(3y)-33.39%
ROE(5y)-23.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.34%
Cap/Sales 1.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.74
Quick Ratio 4.74
Altman-Z -0.31
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)44.73%
Cap/Depr(5y)48.56%
Cap/Sales(3y)3.9%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
EPS Next Y37.52%
EPS Next 2Y26.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.62%
Revenue growth 3Y-14.76%
Revenue growth 5YN/A
Sales Q2Q%-2.46%
Revenue Next Year35.73%
Revenue Next 2Y30%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.46%
OCF growth 3YN/A
OCF growth 5YN/A